Benny Johnson

So last week, we had Pfizer in, which is one of the biggest American pharmaceutical companies.

Today, we have AstraZeneca in with Pascal Soros, which is one of the biggest European pharmaceutical companies.

And the president saw – the president asked us to do three things.

One, to get MFN prices.

to not bankrupt these companies.

He understands that America has to be the center for innovation.

The drug industry needs to innovate.

It's critical for its bottom line.

It's critical for the health of the American people.

And he asked us also to make sure that those companies would keep their promise to reshore this industry.

Our national security purposes for our economy, it's critical.

These companies are making these drugs in the United States.

We were able to achieve all those things, and partially with the visionary help of Pascal, where is he?

Of Pascal Zorias, who understood that innovation and the business doesn't work if everybody is not pulling the oars, if everybody doesn't have the skin in the game.

So the whole world was riding on our shoulders and riding on our dime.

70% of pharmaceutical revenues comes from this country.

We only have 4.2% of the world's population.

And we were paying for 80% or 90% of the innovation here.

And the rest of the world was a free rider.

And Pascal understood that that's not fair.